Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J Confide home-HIV test ownership to be decided by arbitrator.

This article was originally published in The Tan Sheet

Executive Summary

CONFIDE HIV TEST OWNERSHIP HANGS ON ARBITRATION DECISION, which could be handed down in 30 days once attorneys for Johnson & Johnson and former Direct Access Diagnostics President and CEO Elliott Millenson comply with an arbitrator's request for additional information in the wrongful dismissal suit. Former U.S. Court of Appeals Judge John Gibbons, a Newark, New Jersey-based arbitrator for the American Arbitration Association, decided in favor of Millenson on July 16 and asked both parties to submit "remedy" briefs by the week of July 22 to resolve the status of the Confide assets.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts